Disease activity, physical function, and QoL of axial SpA patients with overweight and obesity compared to those with normal BMI
| Normal | Overweight | P-value* | Obesity | P-value* | |
|---|---|---|---|---|---|
| BMI [18.5–25] | BMI [25–30] | BMI [>30] | |||
| (n=183) | (n=174) | (n=100) | |||
| BASDAI (range 0–10) | 3.4 (0–9.2) | 3.5 (0–9.6) | 0.235 | 4.4 (0.6–9.4) | 0.029 |
| ASDAS(CRP) | 2.1 (0–5.2) | 2.1 (0.3–5.1) | 0.983 | 2.7 (0.5–5.7) | 0.000 |
| CRP (mg/L) | 3.0 (0–73) | 3.0 (0–94) | 0.372 | 5.0 (0–82) | 0.000 |
| CRP ≥5 mg/L | 62 (34) | 56 (32) | 0.795 | 53 (53) | 0.001 |
| BASFI (range 0–10) | 2.9 (0–9.1) | 2.7 (0–9.9) | 0.635 | 5.1 (0.1–9.7) | 0.000 |
| ASQoL (range 0–18) | 5.0 (0–17) | 4.0 (0–18) | 0.077 | 8.0 (0–18) | 0.002 |
Values are presented as median (range) or number of patients (%). *P-values compared to patients with normal BMI.